Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam

Author(s):  
Yun-Chu Chen ◽  
Dana E. Moseson ◽  
Coralie A. Richard ◽  
Monica R. Swinney ◽  
Sarena D. Horava ◽  
...  
2012 ◽  
Vol 8 (4) ◽  
pp. 1507-1518 ◽  
Author(s):  
Ana M. Puga ◽  
Ana Rey-Rico ◽  
Beatriz Magariños ◽  
Carmen Alvarez-Lorenzo ◽  
Angel Concheiro
Keyword(s):  

2012 ◽  
Vol 101 (2) ◽  
pp. 576-587 ◽  
Author(s):  
Meredith R. Clark ◽  
Todd J. Johnson ◽  
R. Tyler Mccabe ◽  
Justin T. Clark ◽  
Anthony Tuitupou ◽  
...  

2009 ◽  
pp. 090624002829090
Author(s):  
Tristan P. Learoyd ◽  
Jane L. Burrows ◽  
Eddie French ◽  
Peter C. Seville

2019 ◽  
Vol 41 (4) ◽  
pp. 230-239
Author(s):  
L.F. Kosyanchuk ◽  
◽  
O.I. Antonenko ◽  
T.D. Ignatova ◽  
N.V. Babkina ◽  
...  

2019 ◽  
Vol 9 (01) ◽  
pp. 15-20
Author(s):  
B Pandey ◽  
A B Khan

The aim of the review was to explore the necessity, advantages and different techniques of oral films for enhancing solubility of poorly soluble drugs with an emphasis on the newer, state-of the art technologies, such as 3D printing and hot-melt extrusion (HME). The historical background of oral films is presented along with the regularly used techniques. The modern approach of quality-by-design (QbD) is unravelled, identifying appropriate critical process parameters (CPP) and applied to oral films. A section is devoted modern technologies such as 3D printing and HME of oral films. Oral films are innovative formulations by which poorly soluble drugs have been founds to give positive results in enhancing their solubility and dissolution characteristics. With modern sophisticated techniques, precise mass production of oral films has been given a thrust. Oral films have better patient compliance, improved biopharmaceutical properties, improved efficacy, and better safety. By applying QbD and implementation of modern technologies the newer generation of oral films are yielding promising results


Sign in / Sign up

Export Citation Format

Share Document